Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-081859
Filing Date
2025-06-04
Accepted
2025-06-04 18:44:28
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3392
  Complete submission text file 0000950170-25-081859.txt   4999
Mailing Address 1220 CONCORD AVENUE SUITE 600 CONCORD CA 94520
Business Address 1220 CONCORD AVENUE SUITE 600 CONCORD CA 94520 9252886000
CERUS CORP (Issuer) CIK: 0001020214 (see all company filings)

EIN.: 680262011 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BLVD., SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address
Swisher Daniel N JR (Reporting) CIK: 0001323113 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21937 | Film No.: 251024545